Valneva (VALN)

• Market cap: $478M
• 1 day: 3.19%
• 5 days: -11.58%
• 1 month: -14.33%
• 3 months: -40.48%
• 6 months: -42.41%
• Year to date: -38.62%
• 1 year: -21.32%
• 5 years: -80.6%
• 10 years: -80.6%
• Sector: Healthcare
• Industry: Biotechnology

About: Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Employees: 674